Smart Money Is Betting Big In LLY Options
Smart Money Is Betting Big In LLY Options
High-rolling investors have positioned themselves bearish on Eli Lilly and Co (NYSE:LLY), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in LLY often signals that someone has privileged information.
高倉位投資者看淡Eli Lilly and Co (紐交所:LLY)，散戶交易者需要注意。我們從Benzinga的公開期權數據中發現了這一活動。這些投資者的身份不確定，但LLY的如此重大變化通常意味着有人具有內幕消息。
Today, Benzinga's options scanner spotted 12 options trades for Eli Lilly and Co. This is not a typical pattern.
今天，Benzinga的期權掃描器發現了12個Eli Lilly and Co的期權交易。這不是一個典型的模式。
The sentiment among these major traders is split, with 41% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $50,300, and 11 calls, totaling $569,034.
這些主要交易者的情緒分爲兩種，看好佔41%，看淡佔50%。在我們找到的所有期權中，有一個看跌期權，金額爲50,300美元，有11個看漲期權，總金額爲569,034美元。
Projected Price Targets
預計價格目標
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $630.0 to $960.0 for Eli Lilly and Co over the recent three months.
根據交易活動，看來這些重大投資者正在瞄準Eli Lilly and Co的價格區間，涵蓋最近三個月的630.0美元到960.0美元。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 451.5, with a total volume reaching 20.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $630.0 to $960.0, throughout the last 30 days.
在今天的交易環境中，Eli Lilly and Co的期權平均持倉量爲451.5份，總成交量爲20.00。附帶的圖表描述了過去30天Eli Lilly and Co高價值交易的看漲期權和看跌期權的成交量和持倉量的進展，位於630.0美元到960.0美元的行權價走廊中。
Eli Lilly and Co Option Volume And Open Interest Over Last 30 Days
Eli Lilly and Co過去30天期權成交量和持倉量
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BULLISH | 08/23/24 | $49.8 | $43.0 | $48.24 | $900.00 | $144.7K | 2 | 0 |
| LLY | CALL | TRADE | BEARISH | 07/05/24 | $55.9 | $48.95 | $51.22 | $850.00 | $76.8K | 95 | 0 |
| LLY | CALL | SWEEP | BEARISH | 08/16/24 | $24.45 | $22.5 | $23.2 | $950.00 | $69.5K | 943 | 0 |
| LLY | PUT | TRADE | BEARISH | 06/20/25 | $50.3 | $47.85 | $50.3 | $800.00 | $50.3K | 51 | 0 |
| LLY | CALL | TRADE | NEUTRAL | 08/16/24 | $78.45 | $71.8 | $75.63 | $850.00 | $45.3K | 840 | 0 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 交易 | 看好 | 08/23/24 | $49.8 | $43.0 | $48.24 | $900.00 | $144.7K | 2 | 0 |
| LLY | 看漲 | 交易 | 看淡 | 07/05/24 | $55.9 | $48.95 | $51.22 | $850.00 | $76.8K | 95 | 0 |
| LLY | 看漲 | SWEEP | 看淡 | 08/16/24 | $24.45 | 22.5 | $23.2 | $950.00 | $69.5K | 943 | 0 |
| LLY | 看跌 | 交易 | 看淡 | 06/20/25 | $50.3 | $47.85 | $50.3 | $800.00 | $50.3K | 51 | 0 |
| LLY | 看漲 | 交易 | 中立 | 08/16/24 | $78.45 | $71.8 | $75.63 | $850.00 | $45.3K | 840 | 0 |
About Eli Lilly and Co
關於禮來
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的維津尼奧；馬天尼羅、澤普邦、賈達信、特魯利康、胰島素諾和人用胰島素用於糖尿病；以及用於免疫學的塔吉特和優泰樂。
Eli Lilly and Co's Current Market Status
禮來當前的市場狀態幣
- With a volume of 164,284, the price of LLY is down -0.05% at $897.62.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 32 days.
- LLY的成交量爲164,284，報價爲897.62美元，下跌了0.05%。
- RSI指標暗示該股票可能要超買了。
- 下一步將在32天內發佈。
Expert Opinions on Eli Lilly and Co
關於Eli Lilly and Co的專家意見
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $958.8.
在過去一個月裏，有5位行業分析師分享了他們對這隻股票的看法，提出了平均目標價$958.8。
- An analyst from Morgan Stanley has decided to maintain their Overweight rating on Eli Lilly and Co, which currently sits at a price target of $1023.
- Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Eli Lilly and Co, targeting a price of $1000.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
- An analyst from BMO Capital persists with their Outperform rating on Eli Lilly and Co, maintaining a target price of $1001.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- 摩根士丹利的一位分析師決定維持其對Eli Lilly and Co的超配評級，目前的股價目標爲1023美元。
- b的一位分析師繼續持有禮來的買入評級，目標價爲1000美元。
- Cantor Fitzgerald的一位分析師已經將其評級下調爲超配，將目標價調整爲885美元。
- BMO Capital的一位分析師堅持對禮來保持超買評級，維持目標價爲1001美元。
- Cantor Fitzgerald的一位分析師將其評級下調爲超配，目標價爲885美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly and Co options trades with real-time alerts from Benzinga Pro.
期權交易帶來更高的風險和潛在回報。精明的交易者通過持續教育自己、調整策略、監控多個因子、密切關注市場動態來管理這些風險。通過Benzinga Pro全天實時提醒了解最新的禮來期權交易。
譯文內容由第三人軟體翻譯。